Tien-Li Lee insider trades

Open-market stock purchases and sales by Tien-Li Lee, Chief Executive Officer at Aardvark Therapeutics, Inc, from SEC Form 4 filings since Jan 17, 2023.

Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -65%.

Recent trades

DateStockTradeValue
Feb 9, 2026AARD Aardvark Therapeutics, IncSold (not open market)—
Dec 11, 2025AARD Aardvark Therapeutics, IncBought$101K
Oct 15, 2025AARD Aardvark Therapeutics, IncBought (not open market)—

Companies traded

  • AARD Aardvark Therapeutics, Inc: 7 buys, last Feb 9, 2026
  • SCLX Scilex Holding Co: other filings, last Jan 17, 2023

Get free alerts when Tien-Li Lee files a new trade →